282 related articles for article (PubMed ID: 21310926)
21. JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.
Penzo M; Casoli L; Pollutri D; Sicuro L; Ceccarelli C; Santini D; Taffurelli M; Govoni M; Brina D; Trerè D; Montanaro L
Int J Cancer; 2015 Mar; 136(5):E272-81. PubMed ID: 25273595
[TBL] [Abstract][Full Text] [Related]
22. Forced expression of the histone demethylase Fbxl10 maintains self-renewing hematopoietic stem cells.
Konuma T; Nakamura S; Miyagi S; Negishi M; Chiba T; Oguro H; Yuan J; Mochizuki-Kashio M; Ichikawa H; Miyoshi H; Vidal M; Iwama A
Exp Hematol; 2011 Jun; 39(6):697-709.e5. PubMed ID: 21540074
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer.
Kuang Y; Xu H; Lu F; Meng J; Yi Y; Yang H; Hou H; Wei H; Su S
Cancer Sci; 2021 Jan; 112(1):231-242. PubMed ID: 33091189
[TBL] [Abstract][Full Text] [Related]
24. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.
Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T
J Biol Chem; 2021; 296():100213. PubMed ID: 33779563
[TBL] [Abstract][Full Text] [Related]
25. Regulation of KDM2B and Brg1 on Inflammatory Response of Nasal Mucosa in CRSwNP.
Liu CC; Sun C; Zheng X; Zhao MQ; Kong F; Xu FL; Chen XJ; Wang XX; Zhang M; Xia M
Inflammation; 2019 Aug; 42(4):1389-1400. PubMed ID: 31041569
[TBL] [Abstract][Full Text] [Related]
26. The FBXL10/KDM2B scaffolding protein associates with novel polycomb repressive complex-1 to regulate adipogenesis.
Inagaki T; Iwasaki S; Matsumura Y; Kawamura T; Tanaka T; Abe Y; Yamasaki A; Tsurutani Y; Yoshida A; Chikaoka Y; Nakamura K; Magoori K; Nakaki R; Osborne TF; Fukami K; Aburatani H; Kodama T; Sakai J
J Biol Chem; 2015 Feb; 290(7):4163-77. PubMed ID: 25533466
[TBL] [Abstract][Full Text] [Related]
27. NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.
Kottakis F; Foltopoulou P; Sanidas I; Keller P; Wronski A; Dake BT; Ezell SA; Shen Z; Naber SP; Hinds PW; McNiel E; Kuperwasser C; Tsichlis PN
Cancer Res; 2014 Jul; 74(14):3935-46. PubMed ID: 24853546
[TBL] [Abstract][Full Text] [Related]
28. Histone H3K79 demethylation by KDM2B facilitates proper DNA replication through PCNA dissociation from chromatin.
Kang JY; Park JW; Hahm JY; Jung H; Seo SB
Cell Prolif; 2020 Nov; 53(11):e12920. PubMed ID: 33029857
[TBL] [Abstract][Full Text] [Related]
29. HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys.
Peta E; Sinigaglia A; Masi G; Di Camillo B; Grassi A; Trevisan M; Messa L; Loregian A; Manfrin E; Brunelli M; Martignoni G; Palù G; Barzon L
Oncogene; 2018 Mar; 37(12):1654-1668. PubMed ID: 29335520
[TBL] [Abstract][Full Text] [Related]
30. CBP-triggered KDM2B acetylation accelerates the carcinogenesis of colon cancer.
Qi Y; Zhao Y
J Cell Physiol; 2020 Mar; 235(3):2901-2910. PubMed ID: 31531877
[TBL] [Abstract][Full Text] [Related]
31. Histone demethylase lysine demethylase 5B in development and cancer.
Han M; Xu W; Cheng P; Jin H; Wang X
Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677
[TBL] [Abstract][Full Text] [Related]
32. JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.
Lynch JR; Salik B; Connerty P; Vick B; Leung H; Pijning A; Jeremias I; Spiekermann K; Trahair T; Liu T; Haber M; Norris MD; Woo AJ; Hogg P; Wang J; Wang JY
Leukemia; 2019 Jun; 33(6):1400-1410. PubMed ID: 30622285
[TBL] [Abstract][Full Text] [Related]
33. The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential.
Wong SH; Goode DL; Iwasaki M; Wei MC; Kuo HP; Zhu L; Schneidawind D; Duque-Afonso J; Weng Z; Cleary ML
Cancer Cell; 2015 Aug; 28(2):198-209. PubMed ID: 26190263
[TBL] [Abstract][Full Text] [Related]
34. Biological Functions of the KDM2 Family of Histone Demethylases.
Andricovich J; Tzatsos A
Adv Exp Med Biol; 2023; 1433():51-68. PubMed ID: 37751135
[TBL] [Abstract][Full Text] [Related]
35. SRF is a nonhistone methylation target of KDM2B and SET7 in the regulation of skeletal muscle differentiation.
Kwon DH; Kang JY; Joung H; Kim JY; Jeong A; Min HK; Shin S; Lee YG; Kim YK; Seo SB; Kook H
Exp Mol Med; 2021 Feb; 53(2):250-263. PubMed ID: 33564100
[TBL] [Abstract][Full Text] [Related]
36. The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility.
Zacharopoulou N; Kallergi G; Alkahtani S; Tsapara A; Alarifi S; Schmid E; Sukkar B; Kampranis S; Lang F; Stournaras C
Cancer Biol Ther; 2020 Jun; 21(6):533-540. PubMed ID: 32175798
[TBL] [Abstract][Full Text] [Related]
37. JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes.
Frescas D; Guardavaccaro D; Bassermann F; Koyama-Nasu R; Pagano M
Nature; 2007 Nov; 450(7167):309-13. PubMed ID: 17994099
[TBL] [Abstract][Full Text] [Related]
38. Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.
Cheung N; Fung TK; Zeisig BB; Holmes K; Rane JK; Mowen KA; Finn MG; Lenhard B; Chan LC; So CW
Cancer Cell; 2016 Jan; 29(1):32-48. PubMed ID: 26766589
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4.
Chavdoula E; Anastas V; La Ferlita A; Aldana J; Carota G; Spampinato M; Soysal B; Cosentini I; Parashar S; Sircar A; Nigita G; Sehgal L; Freitas MA; Tsichlis PN
Metabolism; 2024 Jan; 150():155719. PubMed ID: 37935302
[TBL] [Abstract][Full Text] [Related]
40. The epigenetic factor KDM2B regulates cell adhesion, small rho GTPases, actin cytoskeleton and migration in prostate cancer cells.
Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Tsichlis PN; Kampranis SC; Stournaras C
Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):587-597. PubMed ID: 29408056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]